sameAs
Open drug discovery for the Zika virusIllustrating and homology modeling the proteins of the Zika virus.OpenZika: An IBM World Community Grid Project to Accelerate Zika Virus Drug DiscoveryIn silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoniMolecular dynamics simulations of Zika virus NS3 helicase: Insights into RNA binding site activityTuning HERG out: antitarget QSAR models for drug developmentAntitrypanosomal activity and evaluation of the mechanism of action of dehydrodieugenol isolated from Nectandra leucantha (Lauraceae) and its methylated derivative against Trypanosoma cruzi.4D-QSAR: perspectives in drug design.Advances in methods for predicting phase I metabolism of polyphenols.3D-QSAR approaches in drug design: perspectives to generate reliable CoMFA models.In silico prediction of drug metabolism by P450.Virtual screening strategies in medicinal chemistry: the state of the art and current challenges.Natural products as leads in schistosome drug discovery.Modern approaches to accelerate discovery of new antischistosomal drugs.Pred-Skin: A Fast and Reliable Web Application to Assess Skin Sensitization Effect of Chemicals.Chalcone Derivatives: Promising Starting Points for Drug Design.Neolignans from leaves of Nectandra leucantha (Lauraceae) display in vitro antitrypanosomal activity via plasma membrane and mitochondrial damages.Analogues of Marine Guanidine Alkaloids Are in Vitro Effective against Trypanosoma cruzi and Selectively Eliminate Leishmania (L.) infantum Intracellular Amastigotes.Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum.Design of new dopamine D2 receptor ligands: biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581.3D-Pharmacophore mapping of thymidine-based inhibitors of TMPK as potential antituberculosis agents.Fragment-based and classical quantitative structure-activity relationships for a series of hydrazides as antituberculosis agents.In vitro, in silico and in vivo analysis of novel aromatic amidines against Trypanosoma cruzi.Anti-inflammatory and antinociceptive activities of LQFM002 - A 4-nerolidylcatechol derivative.In Silico Chemogenomics Drug Repositioning Strategies for Neglected Tropical Diseases.QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking Activities.Structural and chemical basis for enhanced affinity to a series of mycobacterial thymidine monophosphate kinase inhibitors: fragment-based QSAR and QM/MM docking studies.Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.Synthesis and molecular modelling studies of pyrimidinones and pyrrolo[3,4-d]-pyrimidinodiones as new antiplasmodial compounds.Multi-Descriptor Read Across (MuDRA): A Simple and Transparent Approach for Developing Accurate Quantitative Structure–Activity Relationship ModelsA Perspective and a New Integrated Computational Strategy for Skin Sensitization AssessmentDevelopment of Web and Mobile Applications for Chemical Toxicity PredictionThe antidepressant drug paroxetine as a new lead candidate in schistosome drug discoveryEditorial (Thematic Issue: Drug Metabolism, Toxicology Experimental Determination and Theoretical Prediction: Challenges and Perspectives from a Medicinal Chemistry Point of View)Anti-inflammatory effect of (E)-4-(3,7-dimethylocta-2,6-dienylamino)phenol, a new derivative of 4-nerolidylcatecholBiotransformation of LASSBio-579 and pharmacological evaluation of p -hydroxylated metabolite a N -phenylpiperazine antipsychotic lead compoundDiscovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approachesCombination of docking, molecular dynamics and quantum mechanical calculations for metabolism prediction of 3,4-methylenedioxybenzoyl-2-thienylhydrazoneStructure-based prediction and biosynthesis of the major mammalian metabolite of the cardioactive prototype LASSBio-294
P50
Q22676298-C31D79FD-0D61-40AB-A809-0C09799371C0Q27313484-12C381CA-76C0-4B27-ACEB-EFD0C5F801CCQ27485305-68CB679E-58FF-4CD8-A599-C2244EC82AEAQ28542999-D5A749C1-D8BD-4FA2-861B-B9A619D6FA77Q29048113-AACE3C6B-8467-4AAA-84A2-CD121CC26448Q35164442-1E819E45-A8DA-4D79-A895-94DCA3008D09Q36270667-30A9BB49-74E2-4EE7-A820-C387C85C2399Q37775506-B05A4419-64A4-4901-A764-3E87F328901AQ38183441-FB0E5589-FDF6-437F-935A-157A437C2050Q38203930-8ED87D1B-086C-46E0-B913-D52C5C291C5AQ38247573-04FC39C9-0344-4E5F-B55A-82E33786F2D8Q38254964-B3305820-9E73-4C91-8061-A4E0D91A65ECQ38334179-D4C1B6B4-3E27-4747-B53E-17F8CFDE9C2AQ38807251-3CA233D0-8C95-437A-AC9A-A301869024A4Q38811289-7F46DB6A-2ACC-4FE9-81FC-CE74EC5E8328Q39027317-67B9E833-D305-439E-B32A-93B78F82D296Q39031844-08617399-1634-40CD-8CFF-768C9876B4F2Q39219940-637AB628-BD1F-4CAB-9CAC-FCDEB4CBBBE6Q39994117-E4B15131-6911-4E43-B5D8-DCAD78E91C4BQ40241027-A4A6FE54-0C0C-48CF-8177-23ECC5C297C8Q43110563-8CD565FD-0062-4B98-A465-6CFC5D75A0A0Q43136203-0C08822D-2A4F-49A2-A1BD-8CA614C3CB1CQ46676924-CE29401D-E53B-462F-889B-7570A29732D4Q47371103-390FB1C4-B137-4979-85C2-44650414156EQ50238107-C642C117-62EB-4AC0-93EA-F5E854208370Q50420212-4C6131A4-688F-47AF-9E98-2F0BB5F896CAQ52645960-E874291A-219D-43E2-B727-CA48E6A89BDDQ53149557-261AE7F8-CE3D-439B-9F0D-159F7FA7B4D9Q53480031-FF9FB844-75DB-4A5C-AC01-B6BBC860E7AFQ55252884-D8920A54-9905-4BE5-B28C-E28BCCFCD61CQ56514129-AF5457C1-15D7-4BC5-9D18-E8B0D67A57BEQ56514145-275B1AE6-B8BE-4E82-B1CD-63C1F7086C42Q56514155-75C07C41-3B65-4E4C-A903-EEF424259FF8Q56514272-6A50D4B7-D61B-488A-A530-2D1F560FE8F1Q56514387-E85D9323-62A9-476F-A6C4-4D245BB4AA81Q56514535-0A26848C-90DB-4E8C-8BE7-9293EF9C905AQ56514564-9FBC995B-7A8D-4139-A961-309EEA9A74E2Q56514572-E8DA1922-15F1-4B4C-AC29-B13960916538Q56514700-252143E7-9BC2-42D3-8876-24127907672CQ56514844-FBB3ECF9-F710-4CA2-9139-FB80A6A31D6B
P50
description
Científica y farmacóloga brasileña
@es
cientista
@pt
farmacologe uit Brazilië
@nl
farmacóloga brasilana
@ast
hulumtuese
@sq
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
عالم صيدلية برازيلية
@ar
name
Carolina Horta Andrade
@af
Carolina Horta Andrade
@an
Carolina Horta Andrade
@ast
Carolina Horta Andrade
@bar
Carolina Horta Andrade
@bm
Carolina Horta Andrade
@br
Carolina Horta Andrade
@ca
Carolina Horta Andrade
@co
Carolina Horta Andrade
@cs
Carolina Horta Andrade
@cy
type
label
Carolina Horta Andrade
@af
Carolina Horta Andrade
@an
Carolina Horta Andrade
@ast
Carolina Horta Andrade
@bar
Carolina Horta Andrade
@bm
Carolina Horta Andrade
@br
Carolina Horta Andrade
@ca
Carolina Horta Andrade
@co
Carolina Horta Andrade
@cs
Carolina Horta Andrade
@cy
altLabel
Carolina Andrade
@en
prefLabel
Carolina Horta Andrade
@af
Carolina Horta Andrade
@an
Carolina Horta Andrade
@ast
Carolina Horta Andrade
@bar
Carolina Horta Andrade
@bm
Carolina Horta Andrade
@br
Carolina Horta Andrade
@ca
Carolina Horta Andrade
@co
Carolina Horta Andrade
@cs
Carolina Horta Andrade
@cy
P1053
C-3960-2014
P106
P1960
UpsohXYAAAAJ
P21
P27
P2798
P31
P3829
P496
0000-0003-0101-1492
P569
1983-08-01T00:00:00Z